That’s a wrap on day 2 of #alzforum. Tomorrow, advocates will continue celebrating their successes in the fight to #ENDALZ as they prepare to bring their energized purple passion back home. Thank you @PattyMurray for meeting with Washington State advocates today.
Alzheimer’s Association President & CEO @joannepikedrph celebrates the #ENDALZ advocates at the #alzforum who have been making their voices heard in support of the bipartisan Alzheimer’s Screening and Prevention Act. #ASAPAct
Your voice matters. Make it heard. 📞 Call your members of Congress to urge them to support the bipartisan #ASAPAct so we can make routine Alzheimer’s and dementia blood tests the new standard of care. https://t.co/24rwjRYvDL
📱A quick call can make all the difference in getting Congress to pass the bipartisan #ASAPAct. Tell your representatives to support Medicare coverage of routine Alzheimer’s blood tests today. https://t.co/24rwjRYvDL
While deaths from heart disease decline ⬇️, Alzheimer’s deaths continue to skyrocket ⬆️. Share the facts and join the fight to #ENDALZ: https://t.co/LIhG205MTK.
Family and friends put in long hours caring for their loved ones living with Alzheimer’s and other dementia — many at the expense of their own health and career. Share the facts and join the fight to #ENDALZ. https://t.co/LIhG205MTK
The financial impact of Alzheimer's and other dementias is STAGGERING. Dementia is one of the costliest health conditions to society. Share the facts and join the fight: https://t.co/LIhG205MTK. #ENDALZ
We cannot stand by while Alzheimer's keeps taking people we love. Share the facts, raise awareness and together we can end Alzheimer’s. https://t.co/LIhG205MTK #AlzheimersInAmerica#ENDALZ
It may be your family member, friend, neighbor or co-worker. It may be you. Share the facts and join the fight to end Alzheimer’s. https://t.co/LIhG205MTK #ENDALZ
These numbers underscore the importance of taking charge of our brain health today — no matter our age — to reduce our risk of cognitive decline, Alzheimer’s and other dementia. Share the facts: https://t.co/LIhG205MTK.
Today on #CelebrateScientistsDay, we honor the dedicated minds who are fueling progress toward a world without Alzheimer’s and all other dementia. Thank you for the work you do on behalf of all families impacted. #ENDALZ. ⚗️🥼🔬
Take your fight to new heights this year by joining us on January 29 for our State Advocacy Day in Olympia. We’ll help you share your story with state lawmakers to grow support for others impacted by the disease. https://t.co/c2XA1SU6Cm
In 2025, we made incredible strides in brain health and Alzheimer’s diagnosis and treatment — bringing hope to the millions of Americans who are facing this disease.
💜 Caring for someone with dementia? You’re not alone.
Nov. 7 in Post Falls: Learn about caregiver burnout, dementia & the holidays, home safety & more at the North Idaho Caregiver Conference.
Register: https://t.co/eLAkMFRMV2
💬 Got caregiver questions? We’ve got answers.
Nov. 7 in Post Falls: Sessions on burnout, safety, legal planning & more at the North Idaho Caregiver Conference.
Save your spot: https://t.co/eLAkMFRMV2
#CaregiverResources#NorthIdaho
It’s never too early to put financial plans in place when facing Alzheimer’s. Register for our free, on-demand webinar to get tips on managing someone else’s finances and preparing for care costs: https://t.co/TG8KA8p5uJ.
It was another inspiring weekend at #Walk2EndAlz! Whether you had rain ☔️ or shine ☀️, you showed up determined to lead the way in the fight against Alzheimer's and all other dementia. Thank you! #ENDALZ
The FDA has cleared the first blood test for Alzheimer’s for use in primary care settings specifically to rule out the presence of amyloid, a hallmark of the disease.
“This is another important step toward expanding access to Alzheimer’s disease diagnostic tools,” said our president and chief executive officer @joannepikedrph.
The blood test is intended to help primary care physicians determine which patients do not require Alzheimer’s-related follow-up tests, such as PET scans or cerebrospinal fluid analysis. This can significantly improve the diagnostic process by preventing unnecessary specialized testing for individuals whose cognitive issues stem from non-Alzheimer’s causes.
The Association is committed to ensuring blood tests are used appropriately and effectively across all care settings.
Read our full statement: https://t.co/h7S5ZITrTf.